Laminar, Inc. clinical trials
Acquired by Johnson & Johnson, 2023 · source ↗
The registry lists 2 studies whose lead sponsor is Laminar, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 11, 2025.
Before and after it joined Johnson & Johnson
- First submitted before Laminar, Inc. became part of Johnson & Johnson
- 2
- First submitted after Laminar, Inc. became part of Johnson & Johnson
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Laminar, Inc.2 studies
Something wrong with this grouping? Tell us on the Johnson & Johnson page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Johnson & Johnson studies →
- A Trial Evaluating the Safety and Effectiveness of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial FibrillationCompletedNCT05224375Not applicable
Sponsor listed in the registry: Laminar, Inc. · First submitted before Laminar, Inc. became part of Johnson & Johnson
- Evaluating the Safety and Effectiveness of the Laminar Left Atrial Appendage Closure SystemStatus unknownNCT04807283Not applicable
Sponsor listed in the registry: Laminar, Inc. · First submitted before Laminar, Inc. became part of Johnson & Johnson